Our product portfolio comprises of 350+ Products which is further expanding with our continuous efforts in R&D, Manufacturing & Marketing capabilities
Ceasing Tirzepatide treatment after reaching your weight loss objectives requires careful consideration and professional advice
DFO: deferoxamine
Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or other medicine-related problems
Nausea affects roughly 2540% of patients starting this medication, making it one of the most commonly reported side effects during the first weeks of treatment
At Set Point Weight Loss and Wellness Clinic, we incorporate the latest advancements in medical weight management, including Tirzepatide, a relatively new, once-weekly injectable medication approved by the FDA among adults with obesity or among those who are overweight with one or more weight-related comorbidity, including type 2 diabetes